SPY422.60-0.51 -0.12%
DIA338.78-0.67 -0.20%
IXIC14,271.73+18.47 0.13%

Akebia Therapeutics Q1 EPS $(0.45) Misses $(0.36) Estimate, Sales $52.30M Beat $42.84M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36) by 25 percent. This is a 4.26 percent increase over losses of $(0.47) per share from

05/10/2021 08:10
Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36) by 25 percent. This is a 4.26 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $52.30 million which beat the analyst consensus estimate of $42.84 million by 22.08 percent. This is a 40.89 percent decrease over sales of $88.48 million the same period last year.